医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

EOS imaging Announces 15th Installation in Australia

2018年05月03日 AM01:00
このエントリーをはてなブックマークに追加


 

PARIS

Regulatory News:

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI – Eligible PEA – PME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced the installation of an EOS® system at the Queensland X-Ray radiology practice in the Gold Coast Private Hospital in Southport, Gold Coast, Australia. The system placement is the sixth installation in the last 12 months in Australia. In addition, this installation is the 15th for EOS imaging in Australia, and the 13th system at a private facility in the country.

Queensland X-Ray is one of the largest private radiology groups in the state of Queensland and is part of Sonic Healthcare, an Australia-based global healthcare company. Sonic Healthcare is a leading provider of radiology services in Australia. The Gold Coast Private Hospital opened in March 2016 and offers a full range of services that address both the adult and pediatric populations, with 284 beds and 13 operating theatres. The new Healthscope hospital is co-located with the Gold Coast University Hospital and Griffith University, forming a major part of the Gold Coast’s new ‘Health and Knowledge Precinct’, an emerging health and innovation hub.

“We are committed to providing the best service, care and clinical outcome for our patients,” said Dr Ryan Shulman at Queensland X-Ray. “Providing best in class technology helps us to remain competitive. We are pleased to offer EOS to not only our patients, but also to our referring doctors. They appreciate that EOS exams are safe and provide more data than alternative imaging devices.”

“We are seeing an increased interest in the EOS technology from private practices in several of our key markets,” commented Marie Meynadier, CEO of EOS imaging. “The amount of clinical validation supporting our technology is establishing it as a growing standard of care for imaging across the spectrum of orthopedic point of care organizations. We are proud of our expanding footprint in Australia and of serving patients and physicians there with our low dose, full body 2D/3D solutions.

About EOS imaging

EOS imaging designs, develops and markets EOS®, a major innovative medical imaging solution dedicated to osteoarticular pathologies and orthopaedics combining equipment and services and targeting a $2B per year market opportunity. EOS imaging is currently present in 31 countries, including the United States under FDA agreement, Japan, China and the European Union under CE labelling, through the over 250 installed EOS® platforms representing around one million patient exams every year. Revenues were €37.1M in 2017, e.g. a +32% CAGR over 2012-2017.

For more information, please visit www.eos-imaging.com.

EOS imaging has been selected to integrate the EnterNext © PEA – PME 150 index, composed of 150 French, listed companies on the Euronext markets in Paris.

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

View source version on businesswire.com: https://www.businesswire.com/news/home/20180502006126/en/

CONTACT

EOS imaging
Marie Meynadier
CEO
Ph: +33 (0)1 55 25
60 60
investors@eos-imaging.com
or
Press
Relations (US)

Joanna Zimmerman
The Ruth Group
Ph:
646-536-7006
jzimmerman@theruthgroup.com
or
Investor
Relations (US)

Matt Picciano / Emma Poalillo
The Ruth Group
Ph:
646-536-7008 / 7024
EOS-imagingIR@theruthgroup.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Celltrion and Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a Biosimilar to HERCEPTIN®, for the Treatment of HER2-Overexpressing Breast Cancer for Certain Indications
  • Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
  • Tilray®宣布成立国际顾问委员会
  • 武田和纽约科学院宣布2019年度科学创新者奖获奖人
  • AMRA、身体組成の非侵襲的測定を実現する磁気共鳴診断ソフトウエアアプリケーションのAMRA® Profilerで米国FDAの承認を取得